SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '35F'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_A_RALA600_2 (ESTROGEN RECEPTOR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 6	LEU A 165 LEU A 168 LEU A 152 LEU A 89	None 35F A 1 (-4.5A) None None	0.74A	1errA-3e7oA: undetectable	1errA-3e7oA: 20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 6	ILE A 32 VAL A 40 ILE A 85 ILE A 147	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) None None	0.75A	1uwhA-3e7oA: 20.6	1uwhA-3e7oA: 27.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 6	ILE A 32 VAL A 40 ILE A 85 ILE A 147	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) None None	0.75A	1uwhB-3e7oA: 20.5	1uwhB-3e7oA: 27.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	ILE A 32 LYS A 55 LEU A 77 ASP A 169	35F A 1 ( 4.4A) 35F A 1 ( 4.6A) None None	0.75A	1uwjA-3e7oA: 6.5	1uwjA-3e7oA: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	ILE A 32 LYS A 55 LEU A 77 ILE A 85	35F A 1 ( 4.4A) 35F A 1 ( 4.6A) None None	0.77A	1uwjA-3e7oA: 6.5	1uwjA-3e7oA: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 9	VAL A 40 LYS A 55 LEU A 88 LEU A 106 LEU A 110 MET A 111	35F A 1 ( 4.8A) 35F A 1 ( 4.6A) None None 35F A 1 (-4.5A) None	0.66A	1xkkA-3e7oA: 19.6	1xkkA-3e7oA: 25.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITZ_A_IREA2021_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	3 / 3	LEU A 106 LEU A 110 MET A 111	None 35F A 1 (-4.5A) None	0.52A	2itzA-3e7oA: 20.7	2itzA-3e7oA: 25.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	ILE A 32 VAL A 40 ALA A 53 ILE A 86 LEU A 110 MET A 111	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 (-4.5A) None	0.36A	2y7jA-3e7oA: 24.2	2y7jA-3e7oA: 23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 10	ILE A 32 VAL A 40 ALA A 53 ILE A 86 LEU A 110 MET A 111	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 (-4.5A) None	0.39A	2y7jB-3e7oA: 24.1	2y7jB-3e7oA: 23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 10	ILE A 32 VAL A 40 ALA A 53 ILE A 86 LEU A 110 MET A 111	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 (-4.5A) None	0.39A	2y7jC-3e7oA: 24.3	2y7jC-3e7oA: 23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 10	ILE A 32 VAL A 40 ALA A 53 ILE A 86 LEU A 110 MET A 111	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 (-4.5A) None	0.38A	2y7jD-3e7oA: 24.2	2y7jD-3e7oA: 23.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	5 / 12	VAL A 40 ALA A 53 ARG A 72 LEU A 77 HIS A 149	35F A 1 ( 4.8A) 35F A 1 (-3.6A) None None None	0.95A	3gcsA-3e7oA: 34.4	3gcsA-3e7oA: 50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	8 / 12	VAL A 40 ALA A 53 GLU A 73 LEU A 76 LEU A 77 ILE A 86 LEU A 168 ASP A 169	35F A 1 ( 4.8A) 35F A 1 (-3.6A) None None None None 35F A 1 (-4.5A) None	0.73A	3gp0A-3e7oA: 35.7	3gp0A-3e7oA: 49.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	VAL A 40 GLU A 73 LEU A 76 LEU A 77 HIS A 149 ASP A 169	35F A 1 ( 4.8A) None None None None None	1.00A	3gp0A-3e7oA: 35.7	3gp0A-3e7oA: 49.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	LEU A 106 LEU A 110 MET A 111 ILE A 167	None 35F A 1 (-4.5A) None None	0.53A	3gp0A-3e7oA: 35.6	3gp0A-3e7oA: 49.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	ALA A 53 GLU A 73 LEU A 77 ILE A 86 LEU A 110 LEU A 168	35F A 1 (-3.6A) None None None 35F A 1 (-4.5A) 35F A 1 (-4.5A)	0.74A	3hecA-3e7oA: 34.1	3hecA-3e7oA: 50.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	ALA A 53 LYS A 55 GLU A 73 LEU A 77 ILE A 86 LEU A 110	35F A 1 (-3.6A) 35F A 1 ( 4.6A) None None None 35F A 1 (-4.5A)	0.53A	3hecA-3e7oA: 34.1	3hecA-3e7oA: 50.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	ALA A 53 LYS A 55 LEU A 77 ILE A 86 LEU A 110 ASP A 169	35F A 1 (-3.6A) 35F A 1 ( 4.6A) None None 35F A 1 (-4.5A) None	0.68A	3hecA-3e7oA: 34.1	3hecA-3e7oA: 50.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	5 / 12	VAL A 40 ALA A 53 LYS A 55 LEU A 77 ILE A 86	35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 4.6A) None None	0.68A	3hegA-3e7oA: 34.3	3hegA-3e7oA: 50.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 8	ALA A 53 LYS A 55 GLU A 73 LEU A 106 LEU A 110 MET A 111	35F A 1 (-3.6A) 35F A 1 ( 4.6A) None None 35F A 1 (-4.5A) None	0.45A	3lfaA-3e7oA: 34.8	3lfaA-3e7oA: 50.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_2 (P38A)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	3 / 3	GLU A 73 LEU A 106 LEU A 110	None None 35F A 1 (-4.5A)	0.42A	3ohtA-3e7oA: 8.2	3ohtA-3e7oA: 46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	5 / 12	GLY A 33 VAL A 40 ALA A 53 LYS A 55 LEU A 77	35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 4.6A) None	0.53A	3ohtB-3e7oA: 8.1	3ohtB-3e7oA: 46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_2 (P38A)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	3 / 3	GLU A 73 LEU A 106 LEU A 110	None None 35F A 1 (-4.5A)	0.42A	3ohtB-3e7oA: 8.1	3ohtB-3e7oA: 46.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	7 / 12	VAL A 40 ALA A 53 GLU A 73 LEU A 77 ILE A 86 LEU A 142 HIS A 149	35F A 1 ( 4.8A) 35F A 1 (-3.6A) None None None None None	0.76A	3rgfA-3e7oA: 10.1	3rgfA-3e7oA: 28.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	7 / 12	VAL A 40 ALA A 53 LYS A 55 LEU A 106 MET A 108 LEU A 110 MET A 111	35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 4.6A) None 35F A 1 ( 3.9A) 35F A 1 (-4.5A) None	0.57A	3ug2A-3e7oA: 19.7	3ug2A-3e7oA: 25.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 5	VAL A 40 ILE A 85 MET A 111 ILE A 167	35F A 1 ( 4.8A) None None None	0.25A	4c8bA-3e7oA: 21.0	4c8bA-3e7oA: 23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 5	VAL A 40 ILE A 167 MET A 111 ILE A 157	35F A 1 ( 4.8A) None None None	0.89A	4c8bA-3e7oA: 21.0	4c8bA-3e7oA: 23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	7 / 12	ALA A 53 LYS A 55 GLU A 73 LEU A 77 ILE A 85 HIS A 149 ASP A 169	35F A 1 (-3.6A) 35F A 1 ( 4.6A) None None None None None	0.96A	4c8bB-3e7oA: 21.1	4c8bB-3e7oA: 23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTA_A_ADNA401_1 (APH(2'')-ID)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	5 / 10	ALA A 113 PRO A 154 ILE A 214 LEU A 218 ILE A 119	35F A 1 (-4.9A) None None None None	1.31A	4dtaA-3e7oA: 8.1	4dtaA-3e7oA: 21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	VAL A 40 ALA A 53 LEU A 57 MET A 108	35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 ( 3.9A)	0.76A	4l9iA-3e7oA: 8.4	4l9iA-3e7oA: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 8	GLY A 35 VAL A 40 ALA A 53 LYS A 55 MET A 108 LEU A 168	None 35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 4.6A) 35F A 1 ( 3.9A) 35F A 1 (-4.5A)	1.13A	4l9iB-3e7oA: 21.8	4l9iB-3e7oA: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	5 / 10	ILE A 32 ALA A 53 LYS A 55 ILE A 86 LEU A 110	35F A 1 ( 4.4A) 35F A 1 (-3.6A) 35F A 1 ( 4.6A) None 35F A 1 (-4.5A)	0.44A	4rz7A-3e7oA: 8.3	4rz7A-3e7oA: 17.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	VAL A 40 ALA A 53 GLU A 73 LEU A 142 HIS A 149 ASP A 169	35F A 1 ( 4.8A) 35F A 1 (-3.6A) None None None None	0.98A	4v04A-3e7oA: 19.6	4v04A-3e7oA: 25.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	6 / 12	ALA A 53 LYS A 55 GLU A 73 LEU A 77 LEU A 142 HIS A 149	35F A 1 (-3.6A) 35F A 1 ( 4.6A) None None None None	0.75A	5hi2A-3e7oA: 20.1	5hi2A-3e7oA: 27.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I8F_A_ML1A211_1 (PHENOLIC OXIDATIVE COUPLING PROTEIN)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 6	VAL A 159 ALA A 113 GLN A 117 VAL A 118	None 35F A 1 (-4.9A) 35F A 1 ( 4.5A) None	0.96A	5i8fA-3e7oA: undetectable	5i8fA-3e7oA: 19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGI_A_ZITA402_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	5 / 12	ILE A 214 VAL A 118 ALA A 113 VAL A 159 GLY A 33	None None 35F A 1 (-4.9A) None 35F A 1 ( 4.8A)	1.10A	5igiA-3e7oA: 7.3	5igiA-3e7oA: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	GLY A 33 GLY A 35 VAL A 40 LYS A 55	35F A 1 ( 4.8A) None 35F A 1 ( 4.8A) 35F A 1 ( 4.6A)	0.32A	5izjA-3e7oA: 23.5	5izjA-3e7oA: 26.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	4 / 7	GLY A 33 GLY A 35 VAL A 40 LYS A 55	35F A 1 ( 4.8A) None 35F A 1 ( 4.8A) 35F A 1 ( 4.6A)	0.33A	5j5xA-3e7oA: 23.2	5j5xA-3e7oA: 26.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	8 / 9	ILE A 32 GLY A 33 VAL A 40 ALA A 53 ILE A 86 MET A 108 MET A 111 ASN A 114	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 ( 3.9A) None None	0.80A	5lw1B-3e7oA: 43.2	5lw1B-3e7oA: 70.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	8 / 9	ILE A 32 GLY A 33 VAL A 40 ALA A 53 ILE A 86 MET A 108 MET A 111 LEU A 168	35F A 1 ( 4.4A) 35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 ( 3.9A) None 35F A 1 (-4.5A)	0.57A	5lw1B-3e7oA: 43.2	5lw1B-3e7oA: 70.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	9 / 10	GLY A 33 VAL A 40 ALA A 53 ILE A 86 MET A 108 LEU A 110 MET A 111 VAL A 158 LEU A 168	35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) None 35F A 1 ( 3.9A) 35F A 1 (-4.5A) None None 35F A 1 (-4.5A)	0.54A	5lw1E-3e7oA: 42.9	5lw1E-3e7oA: 70.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	8 / 10	GLY A 33 VAL A 40 ALA A 53 MET A 108 LEU A 110 MET A 111 ASN A 114 VAL A 158	35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 3.9A) 35F A 1 (-4.5A) None None None	0.78A	5lw1E-3e7oA: 42.9	5lw1E-3e7oA: 70.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	8 / 9	GLY A 33 VAL A 40 ALA A 53 MET A 108 LEU A 110 MET A 111 ASN A 114 VAL A 158	35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 3.9A) 35F A 1 (-4.5A) None None None	0.73A	5lw1H-3e7oA: 43.5	5lw1H-3e7oA: 70.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	8 / 9	GLY A 33 VAL A 40 ALA A 53 MET A 108 LEU A 110 MET A 111 VAL A 158 LEU A 168	35F A 1 ( 4.8A) 35F A 1 ( 4.8A) 35F A 1 (-3.6A) 35F A 1 ( 3.9A) 35F A 1 (-4.5A) None None 35F A 1 (-4.5A)	0.48A	5lw1H-3e7oA: 43.5	5lw1H-3e7oA: 70.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZMQ_K_PACK1_0 (SERINE PROTEASE NS3 PEPTIDE PAC-DLY-DLY-DAR)	3e7o	MITOGEN-ACTIVATED PROTEIN KINASE 9 (Homo sapiens)	3 / 3	ALA A 53 VAL A 22 TYR A 26	35F A 1 (-3.6A) None None	0.70A	5zmqH-3e7oA: 2.1	5zmqH-3e7oA: 17.24

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ERR_A_RALA600_2","ESTROGEN RECEPTOR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"LEU A 165;LEU A 168;LEU A 152;LEU A  89","None;35F A   1 (-4.5A);None;None","0.74A","1errA-3e7oA:undetectable",null],["1UWH_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"ILE A  32;VAL A  40;ILE A  85;ILE A 147","35F A   1 ( 4.4A);35F A   1 ( 4.8A);None;None","0.75A","1uwhA-3e7oA:20.6","1errA-3e7oA:20.49"],["1UWH_B_BAXB1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"ILE A  32;VAL A  40;ILE A  85;ILE A 147","35F A   1 ( 4.4A);35F A   1 ( 4.8A);None;None","0.75A","1uwhB-3e7oA:20.5","1uwhA-3e7oA:27.57"],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"ILE A  32;LYS A  55;LEU A  77;ASP A 169","35F A   1 ( 4.4A);35F A   1 ( 4.6A);None;None","0.75A","1uwjA-3e7oA:6.5","1uwhB-3e7oA:27.57"],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"ILE A  32;LYS A  55;LEU A  77;ILE A  85","35F A   1 ( 4.4A);35F A   1 ( 4.6A);None;None","0.77A","1uwjA-3e7oA:6.5","1uwjA-3e7oA:27.30"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"VAL A  40;LYS A  55;LEU A  88;LEU A 106;LEU A 110;MET A 111","35F A   1 ( 4.8A);35F A   1 ( 4.6A);None;None;35F A   1 (-4.5A);None","0.66A","1xkkA-3e7oA:19.6","1uwjA-3e7oA:27.30"],["2ITZ_A_IREA2021_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",3,"LEU A 106;LEU A 110;MET A 111","None;35F A   1 (-4.5A);None","0.52A","2itzA-3e7oA:20.7","1xkkA-3e7oA:25.63"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ILE A  32;VAL A  40;ALA A  53;ILE A  86;LEU A 110;MET A 111","35F A   1 ( 4.4A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 (-4.5A);None","0.36A","2y7jA-3e7oA:24.2","2itzA-3e7oA:25.60"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ILE A  32;VAL A  40;ALA A  53;ILE A  86;LEU A 110;MET A 111","35F A   1 ( 4.4A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 (-4.5A);None","0.39A","2y7jB-3e7oA:24.1","2y7jA-3e7oA:23.52"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ILE A  32;VAL A  40;ALA A  53;ILE A  86;LEU A 110;MET A 111","35F A   1 ( 4.4A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 (-4.5A);None","0.39A","2y7jC-3e7oA:24.3","2y7jB-3e7oA:23.52"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ILE A  32;VAL A  40;ALA A  53;ILE A  86;LEU A 110;MET A 111","35F A   1 ( 4.4A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 (-4.5A);None","0.38A","2y7jD-3e7oA:24.2","2y7jC-3e7oA:23.52"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",5,"VAL A  40;ALA A  53;ARG A  72;LEU A  77;HIS A 149","35F A   1 ( 4.8A);35F A   1 (-3.6A);None;None;None","0.95A","3gcsA-3e7oA:34.4","2y7jD-3e7oA:23.52"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",8,"VAL A  40;ALA A  53;GLU A  73;LEU A  76;LEU A  77;ILE A  86;LEU A 168;ASP A 169","35F A   1 ( 4.8A);35F A   1 (-3.6A);None;None;None;None;35F A   1 (-4.5A);None","0.73A","3gp0A-3e7oA:35.7","3gcsA-3e7oA:50.00"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"VAL A  40;GLU A  73;LEU A  76;LEU A  77;HIS A 149;ASP A 169","35F A   1 ( 4.8A);None;None;None;None;None","1.00A","3gp0A-3e7oA:35.7","3gp0A-3e7oA:49.04"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"LEU A 106;LEU A 110;MET A 111;ILE A 167","None;35F A   1 (-4.5A);None;None","0.53A","3gp0A-3e7oA:35.6","3gp0A-3e7oA:49.04"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ALA A  53;GLU A  73;LEU A  77;ILE A  86;LEU A 110;LEU A 168","35F A   1 (-3.6A);None;None;None;35F A   1 (-4.5A);35F A   1 (-4.5A)","0.74A","3hecA-3e7oA:34.1","3gp0A-3e7oA:49.04"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ALA A  53;LYS A  55;GLU A  73;LEU A  77;ILE A  86;LEU A 110","35F A   1 (-3.6A);35F A   1 ( 4.6A);None;None;None;35F A   1 (-4.5A)","0.53A","3hecA-3e7oA:34.1","3hecA-3e7oA:50.41"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ALA A  53;LYS A  55;LEU A  77;ILE A  86;LEU A 110;ASP A 169","35F A   1 (-3.6A);35F A   1 ( 4.6A);None;None;35F A   1 (-4.5A);None","0.68A","3hecA-3e7oA:34.1","3hecA-3e7oA:50.41"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",5,"VAL A  40;ALA A  53;LYS A  55;LEU A  77;ILE A  86","35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 4.6A);None;None","0.68A","3hegA-3e7oA:34.3","3hecA-3e7oA:50.41"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ALA A  53;LYS A  55;GLU A  73;LEU A 106;LEU A 110;MET A 111","35F A   1 (-3.6A);35F A   1 ( 4.6A);None;None;35F A   1 (-4.5A);None","0.45A","3lfaA-3e7oA:34.8","3hegA-3e7oA:50.41"],["3OHT_A_1N1A1000_2","P38A","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",3,"GLU A  73;LEU A 106;LEU A 110","None;None;35F A   1 (-4.5A)","0.42A","3ohtA-3e7oA:8.2","3lfaA-3e7oA:50.27"],["3OHT_B_1N1B1000_1","P38A","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",5,"GLY A  33;VAL A  40;ALA A  53;LYS A  55;LEU A  77","35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 4.6A);None","0.53A","3ohtB-3e7oA:8.1","3ohtA-3e7oA:46.25"],["3OHT_B_1N1B1000_2","P38A","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",3,"GLU A  73;LEU A 106;LEU A 110","None;None;35F A   1 (-4.5A)","0.42A","3ohtB-3e7oA:8.1","3ohtB-3e7oA:46.25"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",7,"VAL A  40;ALA A  53;GLU A  73;LEU A  77;ILE A  86;LEU A 142;HIS A 149","35F A   1 ( 4.8A);35F A   1 (-3.6A);None;None;None;None;None","0.76A","3rgfA-3e7oA:10.1","3ohtB-3e7oA:46.25"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",7,"VAL A  40;ALA A  53;LYS A  55;LEU A 106;MET A 108;LEU A 110;MET A 111","35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 4.6A);None;35F A   1 ( 3.9A);35F A   1 (-4.5A);None","0.57A","3ug2A-3e7oA:19.7","3rgfA-3e7oA:28.94"],["4C8B_A_0LIA1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"VAL A  40;ILE A  85;MET A 111;ILE A 167","35F A   1 ( 4.8A);None;None;None","0.25A","4c8bA-3e7oA:21.0","3ug2A-3e7oA:25.33"],["4C8B_A_0LIA1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"VAL A  40;ILE A 167;MET A 111;ILE A 157","35F A   1 ( 4.8A);None;None;None","0.89A","4c8bA-3e7oA:21.0","4c8bA-3e7oA:23.51"],["4C8B_B_0LIB1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",7,"ALA A  53;LYS A  55;GLU A  73;LEU A  77;ILE A  85;HIS A 149;ASP A 169","35F A   1 (-3.6A);35F A   1 ( 4.6A);None;None;None;None;None","0.96A","4c8bB-3e7oA:21.1","4c8bA-3e7oA:23.51"],["4DTA_A_ADNA401_1","APH(2'')-ID","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",5,"ALA A 113;PRO A 154;ILE A 214;LEU A 218;ILE A 119","35F A   1 (-4.9A);None;None;None;None","1.31A","4dtaA-3e7oA:8.1","4c8bB-3e7oA:23.51"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"VAL A  40;ALA A  53;LEU A  57;MET A 108","35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 ( 3.9A)","0.76A","4l9iA-3e7oA:8.4","4dtaA-3e7oA:21.24"],["4L9I_B_8PRB601_1","RHODOPSIN KINASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"GLY A  35;VAL A  40;ALA A  53;LYS A  55;MET A 108;LEU A 168","None;35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 4.6A);35F A   1 ( 3.9A);35F A   1 (-4.5A)","1.13A","4l9iB-3e7oA:21.8","4l9iA-3e7oA:23.58"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",5,"ILE A  32;ALA A  53;LYS A  55;ILE A  86;LEU A 110","35F A   1 ( 4.4A);35F A   1 (-3.6A);35F A   1 ( 4.6A);None;35F A   1 (-4.5A)","0.44A","4rz7A-3e7oA:8.3","4l9iB-3e7oA:23.58"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"VAL A  40;ALA A  53;GLU A  73;LEU A 142;HIS A 149;ASP A 169","35F A   1 ( 4.8A);35F A   1 (-3.6A);None;None;None;None","0.98A","4v04A-3e7oA:19.6","4rz7A-3e7oA:17.40"],["5HI2_A_BAXA801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",6,"ALA A  53;LYS A  55;GLU A  73;LEU A  77;LEU A 142;HIS A 149","35F A   1 (-3.6A);35F A   1 ( 4.6A);None;None;None;None","0.75A","5hi2A-3e7oA:20.1","4v04A-3e7oA:25.72"],["5I8F_A_ML1A211_1","PHENOLIC OXIDATIVE COUPLING PROTEIN","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"VAL A 159;ALA A 113;GLN A 117;VAL A 118","None;35F A   1 (-4.9A);35F A   1 ( 4.5A);None","0.96A","5i8fA-3e7oA:undetectable","5hi2A-3e7oA:27.08"],["5IGI_A_ZITA402_1","MACROLIDE 2'-PHOSPHOTRANSFERASE","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",5,"ILE A 214;VAL A 118;ALA A 113;VAL A 159;GLY A  33","None;None;35F A   1 (-4.9A);None;35F A   1 ( 4.8A)","1.10A","5igiA-3e7oA:7.3","5i8fA-3e7oA:19.44"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"GLY A  33;GLY A  35;VAL A  40;LYS A  55","35F A   1 ( 4.8A);None;35F A   1 ( 4.8A);35F A   1 ( 4.6A)","0.32A","5izjA-3e7oA:23.5","5igiA-3e7oA:20.81"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",4,"GLY A  33;GLY A  35;VAL A  40;LYS A  55","35F A   1 ( 4.8A);None;35F A   1 ( 4.8A);35F A   1 ( 4.6A)","0.33A","5j5xA-3e7oA:23.2","5izjA-3e7oA:26.11"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",8,"ILE A  32;GLY A  33;VAL A  40;ALA A  53;ILE A  86;MET A 108;MET A 111;ASN A 114","35F A   1 ( 4.4A);35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 ( 3.9A);None;None","0.80A","5lw1B-3e7oA:43.2","5j5xA-3e7oA:26.11"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",8,"ILE A  32;GLY A  33;VAL A  40;ALA A  53;ILE A  86;MET A 108;MET A 111;LEU A 168","35F A   1 ( 4.4A);35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 ( 3.9A);None;35F A   1 (-4.5A)","0.57A","5lw1B-3e7oA:43.2","5lw1B-3e7oA:70.51"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",9,"GLY A  33;VAL A  40;ALA A  53;ILE A  86;MET A 108;LEU A 110;MET A 111;VAL A 158;LEU A 168","35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);None;35F A   1 ( 3.9A);35F A   1 (-4.5A);None;None;35F A   1 (-4.5A)","0.54A","5lw1E-3e7oA:42.9","5lw1B-3e7oA:70.51"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",8,"GLY A  33;VAL A  40;ALA A  53;MET A 108;LEU A 110;MET A 111;ASN A 114;VAL A 158","35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 3.9A);35F A   1 (-4.5A);None;None;None","0.78A","5lw1E-3e7oA:42.9","5lw1E-3e7oA:70.51"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",8,"GLY A  33;VAL A  40;ALA A  53;MET A 108;LEU A 110;MET A 111;ASN A 114;VAL A 158","35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 3.9A);35F A   1 (-4.5A);None;None;None","0.73A","5lw1H-3e7oA:43.5","5lw1E-3e7oA:70.51"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",8,"GLY A  33;VAL A  40;ALA A  53;MET A 108;LEU A 110;MET A 111;VAL A 158;LEU A 168","35F A   1 ( 4.8A);35F A   1 ( 4.8A);35F A   1 (-3.6A);35F A   1 ( 3.9A);35F A   1 (-4.5A);None;None;35F A   1 (-4.5A)","0.48A","5lw1H-3e7oA:43.5","5lw1H-3e7oA:70.51"],["5ZMQ_K_PACK1_0","SERINE PROTEASE NS3;PEPTIDE PAC-DLY-DLY-DAR","3e7o","MITOGEN-ACTIVATED PROTEIN KINASE 9","Homo sapiens",3,"ALA A  53;VAL A  22;TYR A  26","35F A   1 (-3.6A);None;None","0.70A","5zmqH-3e7oA:2.1","5lw1H-3e7oA:70.51"]]